DFDA

Neostigmine (for Acute Colonic Pseudo-obstruction)

Treatment for Paralytic Ileus And Intestinal Obstruction

Typical Dosage: 2 mg IV over 3-5 minutes

Effectiveness
85%
Safety Score
50%
Clinical Trials
15
Participants
800

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
2 mg IV over 3-5 minutes
Time to Effect
15-30 minutes for initial effect
Treatment Duration
Single dose, repeat if needed
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$750
Side Effect Mgmt:$50
Total Annual:$830
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$976
Cost per Remission
$1,038
Comparison vs Colonoscopic decompression
Cost Difference
$-5,000/year
Less expensive
QALY Difference
+0.05 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Neostigmine (for Acute Colonic Pseudo-obstruction) Outcomes

for Paralytic Ileus And Intestinal Obstruction

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Bradycardia
+15%
Abdominal Cramps
+20%
Nausea/Vomiting
+10%
Salivation
+8%

Sources:

nih.gov
qxmd.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov